Jin Zhao

Jin Zhao


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2013 in Discover Nano
Verified
Journal Article
Open access
PDF file
TKTianshu Kang
Tianshu Kang
RGRongfa Guan
Rongfa Guan
CXChen Xiaoqiang
Chen Xiaoqiang
YSYijuan Song
Yijuan Song
HJHan Jiang
Han Jiang
JZJin Zhao
Jin Zhao
There has been rapid growth in nanotechnology in both the public and private sectors worldwide, but concern about nanosafety exists. To assess size-dependent cytotoxicity on human cancer cells, we studied the cytotoxic effect of three kinds of zinc oxide nanoparticles (ZnO NPs) on human epithelial colorectal adenocarcinoma (Caco-2) cells. Nanoparticles were first characterized by size, distribution, and intensity. Multiple assays have been adopted to measure the cell activity and oxidative stress. The cytotoxicity of ZnO NPs was time dependent and dose dependent. The 24-h exposure was chosen to confirm the viability and accessibility of the cells and taken as the appropriate time for the following test system. The IC50 value was found at a low concentration. The oxidative stress elicited a significant reduction in glutathione with increase in reactive oxygen species and lactate dehydrogenase. The toxicity resulted in a deletion of cells in the G1 phase and an accumulation of cells in the S and G2/M phases. One type of metallic oxide (ZnO) exerted different cytotoxic effects according to different particle sizes. Data from the previous experiments showed that 26-nm ZnO NPs appeared to have the highest toxicity to Caco-2 cells. The study demonstrated the toxicity of ZnO NPs to Caco-2 cells and the impact of particle size, which could be useful in the medical applications.

1 December 2013 in Food Chemistry
Verified
Journal Article
Closed access
JZJin Zhao
Jin Zhao
WLWeijin Lv
Weijin Lv
JWJinlin Wang
Jinlin Wang
JLJianrong Li
Jianrong Li
XLXiaoxiang Liu
Xiaoxiang Liu
JZJunli Zhu
Junli Zhu

6 September 2024 in Food Research International
Verified
Journal Article
Closed access
MGMingxiu Gong
Mingxiu Gong
YYYiwei Yuan
Yiwei Yuan
XSXiaolei Shi
Xiaolei Shi
HHHao Huang
Hao Huang
JLJun Liu
Jun Liu
QXQianqian Xu
Qianqian Xu

24 November 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
QXQianqian Xu
Qianqian Xu
JYJiangcheng Ye
Jiangcheng Ye
MGMingxiu Gong
Mingxiu Gong
YZYi fan Zhang
Yi fan Zhang
YYYiwei Yuan
Yiwei Yuan
JZJin Zhao
Jin Zhao
The search for functional foods with no side effects that can alleviate obesity has been a common trend. Wuniuzao dark tea could be a safe choice. This study aimed to explore whether theabrownin from Wuniuzao dark tea could regulate hepatic lipid metabolism and gut microbiota in mice fed a high-fat diet. In total, fifty 8-week-old male C57BL/6 mice were randomly divided into five treatment groups, including a normal control group, high-fat diet group, positive control group, low-dose theabrownin group, and high-dose theabrownin group. After a 9-week intervention, these mice were selected from each treatment group for sampling. The results showed that the body weight and epididymis fat weight of obese mice fed with theabrownin were decreased. Serum total triglycerides, total cholesterol, and low-density lipoprotein cholesterol, and activities of aspartate aminotransferase and alanine aminotransferase were also decreased. Protein and mRNA expression of fatty acid synthesis and lipid production-related genes of mice fed with theabrownin were downregulated. The gut microbiota composition in the theabrownin group was improved. The study indicated that theabrownin from Wuniuzao dark tea could achieve the liver protection and anti-obesity effects by regulating the Srebp lipid metabolism pathway and bile acid metabolism process, and improving the gut microbiota composition of mice.

28 January 2025 in Food & Function
Verified
Journal Article
Closed access
PDF file
YYYiwei Yuan
Yiwei Yuan
YZYu Zhang
Yu Zhang
CHChunli Hu
Chunli Hu
ZWZhenyu Wang
Zhenyu Wang
QXQianqian Xu
Qianqian Xu
JZJin Zhao
Jin Zhao
An effective intervention for obesity without side effects is needed. Chrysanthemum may be the preferred choice due to its influence in the improvement of glycolipid metabolism. This study assessed the efficacy of chrysanthemum and its flavonoids in mitigating high-fat diet (HFD) induced obesity, focusing on the integrity of the intestinal barrier, inflammation, and gut microbiota. Fifty male C57BL/6J mice were divided into 5 groups randomly: normal control (NC), HFD, HFD with chrysanthemum aqueous extract (CM), HFD with a low-dose flavonoid extract of chrysanthemum (FLL), and HFD with a high-dose flavonoid extract of chrysanthemum (FLH). The results showed that after 9 weeks of intervention with CM, FLL and FLH, the body weight and blood lipid levels of mice were reduced. The chrysanthemum treatment regimens down-regulated the gene expression and protein levels of TLR4, MyD88, TRAF6 and NF-κB, upregulated the gene expression levels of ZO-1 and occludin, and decreased the levels of LPS and diamine oxidase (DAO) in the serum. With CM, FLL and FLH, the levels of the inflammatory factors IL-1β, TNF-α, and IL-6 were decreased, and the abundance of pernicious bacteria Lachnoclostridium, Streptococcus and Enterococcus was decreased. Notably, the purified chrysanthemum flavonoid extract showed greater effects as compared to the CM. The study demonstrated that chrysanthemum extracts could achieve anti-obesity effects by strengthening the intestinal barrier function, relieving inflammation and modulating the gut microbial composition.

24 February 2025 in Food Research International
Verified
Journal Article
Closed access
ZWZhenyu Wang
Zhenyu Wang
YZYifang Zhang
Yifang Zhang
XSXiaolei Shi
Xiaolei Shi
XLXiaojun Li
Xiaojun Li
SQShangxiong Qi
Shangxiong Qi
JZJin Zhao
Jin Zhao